Background and Thesis
Aehr Test Systems is a small-cap supplier of test and burn‑in systems used to stress‑test semiconductors before they are assembled into final products. For years the company’s growth was driven by silicon‑carbide (SiC) chips used in electric vehicles (EVs). In fiscal 2024, SiC customers accounted for more than 90 % of Aehr’s revenue. That dependence became a liability in 2024 and early 2025: high interest rates and a pullback in EV spending caused automotive chip makers to slash orders, and by early 2025 SiC revenue was tracking at <40 % of total revenue. Aehr’s management recognised that its SiC market had become cyclical and turned to new markets where its equipment can add value.
Shift toward AI and other new markets
- AI processors: Modern artificial‑intelligence chips pack dozens of cores and high‑bandwidth memory into a single package, generating so much heat that traditional testers struggle to safely stress‑test them. Aehr developed an ultra‑high‑power Sonoma system that can deliver hundreds of amps of current per chip and test these devices either wafer‑level or package‑level. In 2024 the company signed its first hyperscaler customer for packaged‑part burn‑in (PPBI) and began shipping systems in fiscal 2025. By the April 2025 quarter, burn‑in for AI processors represented over 35 % of Aehr’s revenue—roughly matching the shrinking SiC business. Management believes the AI market is three to five times larger than the SiC market.
- Wafer‑level burn‑in (WLBI): On Aug. 26 2025 Aehr announced that a leading AI‑processor supplier ordered a WLBI evaluation program. The paid evaluation includes a custom 300‑mm WaferPak contactor and development of a production WLBI test program using Aehr’s FOX‑XP™ systems. The program will test whether Aehr’s system can deliver hundreds of amps to each chip and is expected to take three to six months; it could lead to full‑scale adoption. Aehr emphasised that WLBI can detect faulty processors before they are packaged with expensive memory chips, saving customers money. Although no volume order is guaranteed, the evaluation underscores the potential of this market.
- New orders from a hyperscaler: On July 22 2025 Aehr revealed that a large hyperscale data‑center customer ordered eight Sonoma PPBI systems, and on Aug. 25 the same customer placed an additional order for six Sonoma systems, boosting Aehr’s share price more than 35 %. CEO Gayn Erickson said the rapid follow‑on orders show the value of Aehr’s high‑power burn‑in systems and that the customer plans to expand capacity and add more AI devices. The AI chip boom is attracting tech giants such as Microsoft, Amazon, Alphabet and Meta, all of which are building their own AI processors. Analysts estimate the AI‑chip market could grow from ~US$60 billion in 2023 to more than US$600 billion by 2032, implying a long runway for testing equipment suppliers.
- Other opportunities: Aehr is expanding into gallium‑nitride (GaN) semiconductors, data‑storage devices, and silicon photonics. During the fiscal 2025 earnings call, management noted that these markets could collectively be 3–5 times larger than the SiC opportunityinvesting.com. In July 2025, Aehr received a Wafer‑level burn‑in order from a GaN customer believed to be Navitas, a GaN supplier to Nvidia (speculative, not confirmed)fool.com.
The emerging thesis is that Aehr is pivoting from a cyclical EV‑driven business to a broader portfolio in AI, GaN and photonics. If hyperscalers and chip makers adopt Aehr’s high‑power burn‑in systems as their standard, the company could become a key supplier to the AI infrastructure build‑out.
Recent Earnings and Financial Performance
Aehr’s fiscal year ends on May 31. FY2025 results (released July 8 2025) showed that the transition away from SiC has been painful:
| Period | Revenue | GAAP net income (loss) | Non‑GAAP net income (loss) | Commentary |
|---|---|---|---|---|
| Q4 FY2025 (March–May 2025) | US$14.1 millionrevenue vs US$16.6 million in Q4 FY2024 | –US$2.9 million vs US$23.9 millionprofit a year earlier | –US$0.2 million vs US$24.7 million | Revenue fell 15 %, reflecting delayed SiC orders and the nascent AI business. Management blamed tariff‑related order delays and the EV slowdown. |
| FY2025 | US$59.0 millionrevenue vs US$66.2 million in FY2024. | –US$3.9 million vs US$33.2 millionprofit. | US$4.6 millionnon‑GAAP profit. | Revenue decline and inventory build led to negative cash flow. SiC represented <40 % of revenue while AI burn‑in contributed >35 %. |
Other key metrics:
- Backlog: US$15.2 million at year‑end (effective backlog with revenue deferred for service agreements was US$16.3 million). Backlog has since grown with the July/August orders.
- Cash: US$26.5 million, with no long‑term debt.
- Orders: In fiscal 2025 the company shipped a high‑power wafer‑level system to its first AI customer and shipped its first production AI packaged‑part systems.
Guidance: During the July 2025 earnings call, Aehr declined to provide a revenue forecast for FY2026. Erickson cited persistent weakness in the core SiC business and tariff‑related order delays. Management expects order growth across all segments, except possibly SiC, and believes new orders will ramp in the second half of FY2026. Analysts on investing sites project revenue of about US$59.9 million in FY2025 and US$74.4 million in FY2026, but these are unofficial estimates.
What Analysts Are Saying
Wall Street price targets and ratings
| Source | Rating/Recommendation | Price target (12‑month) | Notes |
|---|---|---|---|
| TipRanks (Aug 2025) | Moderate Buy based on three analysts (1 Buy, 2 Hold) | US$19.00 average (range US$19–19) | ~5 % upside from the late‑Aug trading price. |
| AInvest (Jul 22 2025) | Brokerage consensus Outperform; Buy rating maintained by Craig‑Hallum’s Chase Knickerbocker | US$15 average (range US$14–US$16) | Implies ~9 % downside vs July price; emphasises Aehr’s unique position offering both wafer‑level and packaged burn‑in for AI chips. |
| Zacks Investment Research (Aug 26 2025) | Zacks Rank #4 (Sell) | Not provided | Zacks notes high implied volatility in September options and that no analysts have raised earnings estimates. The consensus estimate for the current quarter fell from US$0.03 to US$0.01 per shareover the past 60 days. |
Commentary and concerns
- Seeking Alpha analysts: A contributor upgraded Aehr from Sell to Hold after the Aug 25 hyperscaler orders because “the narrative has shifted from EVs to AI.” Yet he cautioned that Aehr finished FY2025 with revenue below expectations and negative free cash flow, and that the company declined FY2026 guidance due to SiC weakness and tariff delays. He expressed concern about margin compression and valuation.
- AAII: As of Aug 25 2025, none of the three Wall Street analysts updated their ratings. AEHR received a value grade of F, indicating it is “ultra expensive,” but it scored 97 for momentum, reflecting the strong price rally.
- MarketBeat: With few analysts covering the stock, MarketBeat does not provide a consensus rating. It notes expected EPS growth of 120 % in the coming year (from US$0.10 to US$0.22), 20.74 % of shares sold short, high institutional ownership (~70 %), and insider sales of roughly US$507 k during the last quarter—a sign that management may be taking advantage of the rally.
- Options market: Zacks highlights that the Sept. 19 2025 $2.50 put for AEHR had among the highest implied volatility across equity options. High implied volatility suggests traders expect a large move, either up or down, and may open opportunities for selling premium. Zacks points out that Aehr is rated a Sell and that the consensus earnings estimate for the current quarter has declined, indicating cautious sentiment.
Why People Are Talking About AEHR
1. Hyperscaler orders and momentum trade
The stock’s 42 % rally on Aug 25–26 2025 followed news that a large cloud provider ordered six additional Sonoma systems just a month after ordering eight. Investors interpreted the follow‑on order as evidence that the AI customer is rapidly scaling capacity. The CEO’s statement that the customer plans to expand capacity and add additional AI devices fuelled speculation about a long‑term relationship. The hyperscaler’s identity is undisclosed, but it is likely one of the tech giants (Google, Microsoft, Amazon or Meta) which are building their own AI chips. Aehr’s equipment could become essential for stress‑testing these chips.
2. Exposure to AI boom versus EV slump
In FY2025 Aehr’s SiC revenue collapsed due to the EV slowdown; the company’s largest EV customer deferred orders because of high interest rates and slower EV adoption. At the same time, demand for AI processors is accelerating as hyperscalers and chip designers race to build custom accelerators. Aehr is one of the few suppliers with both wafer‑level and package‑level high‑power burn‑in systems. For traders, this makes AEHR a high‑beta way to play the AI‑hardware boom and a diversification away from the EV cycle.
3. Speculation on future orders
The August evaluation order for wafer‑level burn‑in suggests that at least one AI‑chip maker is considering Aehr’s technology. Success in this evaluation could lead to a volume purchase, which would materially increase revenue. However, the program is expected to take up to six months, and there is no guarantee of a follow‑on order. Traders are betting that a positive outcome will result in a pipeline of orders across multiple AI customers.
4. Short interest and volatility
Around 20.7 % of AEHR’s float is sold short. With such a large short interest, good news can trigger short squeezes, as seen on Aug 25 when the stock jumped ~40 %. Conversely, disappointing earnings or order cancellations could prompt sharp declines. Zacks’ high implied volatility alert underscores that options traders expect big swings. Traders should be prepared for volatility and consider risk‑managed strategies (e.g., selling high‑volatility options or position sizing).
5. Valuation concerns
Despite the potential, Aehr trades at a lofty valuation relative to its earnings. The stock climbed from around US$6 in October 2024 to the mid‑$20s by August 2025, yet FY2025 revenue declined 11 % and the company reported a net loss. The average analyst price target of US$19 implies limited upside from current levels. Investors are paying a premium for future growth that depends on successful adoption of Aehr’s burn‑in systems by AI and GaN customers. As Seeking Alpha analysts warn, margins could compress because AI equipment may carry lower gross margins than the mature SiC products.
6. Guidance uncertainty
Aehr has declined to provide FY2026 guidance due to uncertainties in SiC demand and tariffs. Without concrete revenue targets, traders must rely on anecdotal order news to gauge momentum. Positive headlines may fuel rallies, while a lack of order announcements could dampen enthusiasm.
Bottom Line for Traders
Aehr Test Systems sits at the intersection of two powerful but volatile trends: a slumping EV SiC market and a booming AI hardware market. Recent hyperscaler orders have transformed the narrative from one of decline to one of opportunity, and the company is racing to diversify its customer base. Traders are drawn to AEHR because:
- The stock responds dramatically to order news—both rallies and sell‑offs.
- It offers leveraged exposure to the AI build‑out, with a unique portfolio of high‑power burn‑in systems.
- High short interest and options activity create opportunities for momentum and options strategies.
However, caution is warranted. Fiscal 2025 saw revenue shrink and cash burn, and management refused to provide guidance. The AI opportunity is substantial, but adoption is in the early stages; evaluation programs must convert into production orders to justify today’s valuation. Analysts remain divided: some see limited upside at current prices while others downgrade the stock due to earnings pressure. Traders should monitor upcoming earnings releases (the next earnings date is Oct. 9 2025, according to Yahoo Finance) and future order announcements. Position sizing and risk management are essential given AEHR’s high beta and option volatility.
